The Venture Codex Logo

The Venture Codex

AyurMaya

1000 Winter Street, Suite 4500, Waltham, Massachusetts, 02451, United States

Overview

Venture capital fund managed by Matrix Capital Management.

Deals ยท 12mo

1

Stage focus

Series B
Series C

Geographic focus

United States

Sector focus

Finance
Financial Services
Venture Capital

Investment portfolio

7rounds
NAMEDATESIZE
Solve Therapeutics
Nov 2025Participated
$120 MOther Equity
Endeavor BioMedicines
Apr 2024Led
$133 MSeries C
Alumis
Mar 2024Participated
$259 MSeries C
ReCode Therapeutics
Sep 2023Participated
$50 MSeries B
ElevateBio
May 2023Led
$401 MSeries D
ACELYRIN
Sep 2022Participated
$300 MSeries C
ReCode Therapeutics
Jun 2022Led
$120 MSeries B
Solve Therapeutics
Nov 2025Participated
$120 MOther Equity
Endeavor BioMedicines
Apr 2024Led
$133 MSeries C
Alumis
Mar 2024Participated
$259 MSeries C
ReCode Therapeutics
Sep 2023Participated
$50 MSeries B
ElevateBio
May 2023Led
$401 MSeries D
ACELYRIN
Sep 2022Participated
$300 MSeries C
ReCode Therapeutics
Jun 2022Led
$120 MSeries B
7
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

AyurMaya: 7 funding rounds are recorded in the selected participation categories.All available history.
AyurMaya: 7 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B11
Series C+22
Other Equity01

Monthly Deal Activity

AyurMaya: 7 deals are recorded across 53 months.All available history.
AyurMaya: 7 deals are recorded across 53 months. All available history
MonthDeals
Jun '221
Jul '220
Aug '220
Sep '221
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '241
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '251
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

AyurMaya: Health & Life Sciences is the largest displayed sector by deal count (7 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

AyurMaya: Health & Life Sciences is the largest displayed sector by deal count (7 deals). All available history
SectorDeals
Health & Life Sciences7

Deal Size Distribution

AyurMaya: 7 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

AyurMaya: 7 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M1
$100M-$250M3
$250M-$500M3
$500M-$1B0
$1B+0

Deals By Geography

AyurMaya: United States has the largest recorded deal count among the displayed regions (7 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

AyurMaya: United States has the largest recorded deal count among the displayed regions (7 deals). All available history
RegionDeals
United States7
AyurMaya: 20 co-investors are shown, with Ally Bridge Group sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

AyurMaya: 20 co-investors are shown, with Ally Bridge Group sharing 3 recorded deals. All available history
Co-investorShared deals
Ally Bridge Group3
Samsara BioCapital3
Surveyor Capital3
Amgen Ventures2
EcoR1 Capital2
Fidelity Management & Research Company2
Invus2
Leaps by Bayer2
MPM Capital2
Omega Funds2
OrbiMed2
Piper Heartland Healthcare Capital2
SymBiosis2
venBio Partners2
Woodline Partners2
Abingworth1
abrdn1
Access Biotechnology1
Alexandria Venture Investments1
Avidity Partners1

Investment Strategy

AyurMaya: Led accounts for 43% and participating for 57% of round participation.All available history.
AyurMaya: Led accounts for 43% and participating for 57% of round participation. All available history
CategoryDeals (count)Share (%)
Led343%
Participating457%
AyurMaya: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
AyurMaya: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led3100%

Team

No team members found for this fund.